| Financial Year |
March 31 2023 |
| Monetary Funds |
400,121,234.66 |
| Held-for-trading Financial Assets |
422,159,742.44 |
| Notes Receivable |
31,025,250.30 |
| Accounts Receivable |
149,406,076.82 |
| Advances to Suppliers |
1,219,902.29 |
| Other Receivables |
628,316.90 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
159,474,373.19 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
16,851,944.36 |
| Total Current Assets |
1,194,301,529.33 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
124,042,841.59 |
| Fixed Assetes |
260,850,028.06 |
| Under-construction Projects |
24,173,770.84 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
44,116,450.68 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
69,917.25 |
| Deferred Income Tax Assets |
35,534,667.27 |
| Other Non-Current Assets |
4,058,291.15 |
| Sub-Total of Non-Current Assets |
492,845,966.84 |
| Total Assets |
1,687,147,496.17 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
50,000,000.00 |
| Accounts Payable |
120,601,073.93 |
| Accounts Received In Advance |
3,595,377.45 |
| Employee Compensation Payable |
17,867,360.96 |
| Taxes Payable |
26,217,496.22 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
6,290,774.00 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
2,902,227.96 |
| Sub-Total of Current Liabilities |
442,763,151.85 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
323,961.37 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
23,280,335.11 |
| Total Liabilities |
466,043,486.96 |
| Paid-In Capital(Or Share Stock) |
378,912,000.00 |
| Capital Surplus |
354,600,633.13 |
| Surplus Reserve |
86,900,468.86 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
400,690,907.22 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,221,104,009.21 |
| Owner's Equity（Stockholder's Equity） |
1,221,104,009.21 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,687,147,496.17 |
